Partner Content Partner Content Ablation Devices Market will achieve 10%+ CAGR from 2019 to ... Ablation Devices Market will cross $25bn by 2025
Oncology Treating primary bone cancer: The potential of listeria-base... In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
